Perimeter Solutions, Inc.
PRMPerimeter Solutions, Inc. (PRM) is a provider of firefighting and fire safety solutions, specializing in innovative products for wildfire prevention and suppression. The company develops and manufactures fire retardants, foams, and other related equipment primarily for use by government agencies, military, and industrial sectors to combat large-scale fires and enhance perimeter defense. It aims to improve fire management efficiency through advanced chemical formulations and technology.
Company News
Perimeter Solutions reported Q1 2026 net income of $72.9M with net sales increasing 74% to $125.1M, driven by the MMT acquisition and strong performance across both Fire Safety and Specialty Products segments. The company secured key five-year contracts with the U.S. Defense Logistics Agency and California Department of Forestry, while Adjusted E...
The Schall Law Firm is investigating Perimeter Solutions, Inc. (NYSE: PRM) for potential securities law violations, alleging the company issued false or misleading statements or failed to disclose material information to investors. The firm is seeking shareholders who suffered losses to participate in the investigation.
The Schall Law Firm is investigating Perimeter Solutions, Inc. (NYSE: PRM) for potential securities law violations, alleging the company issued false or misleading statements and failed to disclose material information to investors. Shareholders who suffered losses are encouraged to participate in the investigation.
Short sellers are heavily targeting 10 stocks with short interest exceeding 40% of float. Choice Hotels and Avis Budget lead with over 50% short interest, while Lucid Group, Hertz Global, and crypto/semiconductor plays like Marathon Digital and CleanSpark also face significant bearish positioning. Traders are watching for potential squeeze opport...
Perimeter Solutions reported full year 2025 net sales growth of 16% to $652.9M, with Adjusted EBITDA increasing 18% to $331.7M. However, the company posted a net loss of $206.4M ($1.37 per diluted share) compared to a $5.9M loss in 2024, primarily due to $435.2M in founders advisory fees. The company completed the acquisition of Medical Manufactu...
